CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy
Title:
CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy
Author:
Ennishi, D. Takeuchi, K. Yokoyama, M. Asai, H. Mishima, Y. Terui, Y. Takahashi, S. Komatsu, H. Ikeda, K. Yamaguchi, M. Suzuki, R. Tanimoto, M. Hatake, K.